The store will not work correctly when cookies are disabled.
7-methyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carbaldehyde
ID: ALA5184254
PubChem CID: 11820222
Max Phase: Preclinical
Molecular Formula: C10H8N2O3
Molecular Weight: 204.19
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1C=O
Standard InChI: InChI=1S/C10H8N2O3/c1-5-2-7-8(3-6(5)4-13)12-10(15)9(14)11-7/h2-4H,1H3,(H,11,14)(H,12,15)
Standard InChI Key: JAUXPMUJGITPSK-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
-1.0705 0.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3560 0.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 0.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 -0.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3541 -0.8224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0705 -0.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0705 0.8270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 0.4143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 -0.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0705 -0.8233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 0.8270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 -0.8233 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7852 0.8266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7852 -0.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4998 0.4140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
4 10 1 0
8 11 2 0
9 12 2 0
1 13 1 0
6 14 1 0
13 15 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 204.19 | Molecular Weight (Monoisotopic): 204.0535 | AlogP: 0.34 | #Rotatable Bonds: 1 |
Polar Surface Area: 82.79 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.12 | CX Basic pKa: ┄ | CX LogP: 0.86 | CX LogD: 0.86 |
Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.52 | Np Likeness Score: -0.33 |
References
1. Jiang X, Wu K, Bai R, Zhang P, Zhang Y.. (2022) Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities., 229 [PMID:34998058] [10.1016/j.ejmech.2021.114085] |